SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is facing intense bearish pressure and sentiment, with investors expressing significant frustration over consistent downward price action despite positive earnings and strategic partnerships like the recent Mastercard stablecoin deal. Many in the community are debating whether to hold through the volatility as a long-term fintech play or to capitulate, while others suggest the stock is being heavily suppressed by short sellers and broader macroeconomic fears surrounding private credit and geopolitical conflict.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending as market participants debate whether recent price consolidation and integration with financial infrastructure point to a breakout or a prolonged period of manipulation. The community remains deeply polarized, with long-term holders focusing on institutional adoption and potential regulatory clarity, while critics highlight the token's large supply and price correlation with broader market movements.

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.

CytomX Therapeutics Inc

CytomX Therapeutics is trending following a massive volume surge and significant price action fueled by positive expansion data for its Varseta-M candidate in colorectal cancer, which has led multiple analysts to raise their price targets. The community is heavily focused on the drug's potential as a clinical game-changer, while active traders continue to debate the balance between its promising pipeline, recent institutional accumulation, and the lingering threat of future stock dilution.

Better Home & Finance Holding Co. engages in the provision of comprehensive homeownership services. It offers mortgage loans, real estate agent services, and title and homeowner's insurance services. The company was founded in 2014 and is headquartered in New York, NY.

Better Home & Finance Holding Co. - Ordinary Shares - Class A

Better Home & Finance Holding Co.

Better Home & Finance is currently experiencing significant market volatility as investors weigh the stock's long-term potential in AI-driven mortgage origination against intense pressure from heavy short interest. The community remains deeply divided, with bulls pointing to potential explosive growth from the Tinman platform and high-profile partnerships, while bears continue to highlight recent price declines and the risks associated with the stock's previous high-volatility trading cycles.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies is trending as investors digest a massive $125 million institutional funding round for Eightco Holdings, which includes high-profile support from ARK Invest and Kraken. The community is actively debating the company's aggressive strategy to pivot into OpenAI and Beast Industries equity while maintaining a substantial Ethereum treasury, with sentiment divided between enthusiasm for the firm's pivot into AI-linked assets and skepticism regarding shareholder dilution.

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.

Cingulate Inc

Cingulate Inc. is trending as investors accumulate shares ahead of critical upcoming catalysts, including a highly anticipated U.S. patent approval and a May 31, 2026, PDUFA date for its ADHD treatment, CTx-1301. The community is focused on the stock's low-float structure and recent institutional filings, with many debating the potential for a significant breakout driven by the company's proprietary delivery platform and a massive addressable market.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is seeing increased market attention driven by a combination of strong revenue growth from its core product and persistent speculation surrounding potential M&A activity. The community is actively debating the credibility of buyout rumors while focusing on the company's recent move toward profitability and the strategic value of its pipeline assets.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

XRP is experiencing heightened discussion driven by significant institutional adoption, including the recent launch of several spot XRP ETFs and increased liquidity from global financial partnerships. While the community remains divided between those actively accumulating during price volatility and vocal skeptics questioning long-term utility, there is a strong focus on the asset's potential role in future cross-border payment systems.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore is trending as the Trump administration invokes the Defense Production Act to prioritize the restart of its California pipeline system to address national energy security concerns. While the company faces ongoing legal challenges from state regulators, the community is actively debating the potential for a massive short squeeze and long-term upside as federal intervention attempts to bypass local environmental hurdles.

Evolv Technologies Holdings, Inc. engages in the manufacture and development of security screening products. It also provides artificial intelligence-based security screening solutions for industries including casinos, industrial workplaces, schools, and ticketed venues. The company was founded by Anil R. Chitkara and Michael Philip Ellenbogen in July 2013 and is headquartered in Waltham, MA.

Evolv Technologies Holdings Inc - Ordinary Shares - Class A

Evolv Technologies Holdings is trending as the company moves past financial restatement issues and an FTC inquiry, with recent positive Q4 earnings, new leadership, and regained NASDAQ compliance. This is sparking community discussions on its growth prospects within the AI-driven public safety sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$HGBL 2026 will be a strong yeae but they need a good earnings call in this market and they did not deliver. Sell pressure on for now

StockTwits for iOS

Heritage Global Inc

 2026 will be a strong yeae but they need a good earnings call in this market and they did not deliver. Sell pressure on for now